Get the Stockscreener App
8.98
8.92%
-0.88
Pre-market:
9.72
0.74
+8.24%
Portage Biotech Inc stock is traded at $8.98, with a volume of 238.33K.
It is down -8.92% in the last 24 hours and up +116.39% over the past month.
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.
See More
Previous Close:
$9.86
Open:
$9.64
24h Volume:
238.33K
Relative Volume:
0.21
Market Cap:
$11.11M
Revenue:
-
Net Income/Loss:
$-67.28M
P/E Ratio:
-0.0949
EPS:
-94.66
Net Cash Flow:
$-9.80M
1W Performance:
+33.04%
1M Performance:
+116.39%
6M Performance:
+59.22%
1Y Performance:
+85.08%
1-Day Range:
$8.7001
$10.14
1-Week Range:
$7.00
$15.82
52-Week Range:
$2.098
$23.01
Portage Biotech Inc Stock (PRTG) Company Profile
Compare PRTG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRTG
Portage Biotech Inc
|
8.98 | 11.11M | 0 | -67.28M | -9.80M | -94.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
492.42 | 124.91B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
587.85 | 60.05B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
594.65 | 35.88B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
241.97 | 29.83B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
249.13 | 24.58B | 3.81B | -644.79M | -669.77M | -6.24 |
Portage Biotech Inc Stock (PRTG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Mar-07-22 | Initiated | H.C. Wainwright | Buy |
| Sep-21-21 | Initiated | Oppenheimer | Outperform |
| Sep-02-21 | Initiated | B. Riley Securities | Buy |
| Aug-19-21 | Initiated | Cantor Fitzgerald | Overweight |
Portage Biotech Inc Stock (PRTG) Latest News
Portage Biotech Inc (PRTG) may enjoy gains as insiders got busy in the recent days - knoxdaily.com
PRTG Stock on the Rise: A Promising Investment - investchronicle.com
Short Interest in Portage Biotech Inc. (NASDAQ:PRTG) Rises By 2,134.8% - Defense World
SoftBank Group (OTCMKTS:SFTBF) Stock Crosses Below 200-Day Moving Average – What’s Next? - Defense World
iAnthus Capital Holdings, Inc. (OTCMKTS:ITHUF) Short Interest Up 2,600.0% in March - Defense World
Corning Natural Gas (OTCMKTS:CNIG) Shares Pass Below 200-Day Moving Average – Here’s What Happened - Defense World
Scorpio Gold (OTCMKTS:SRCRF) Share Price Crosses Below 200 Day Moving Average – What’s Next? - Defense World
Portage Biotech (PRTG) Resumes Key Clinical Trial Phase - GuruFocus
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Nasdaq Gains Over 50 Points; JPMorgan Posts Upbeat Earnings - Benzinga
Exec Edge Launches Research Coverage with Initiation Notes on FLD, CLYM, STKS, REX - Yahoo Finance
CVS Health Corporation (CVS): A Bull Case Theory - Yahoo Finance
Biotech CEOs, VCs urge Cassidy, Senate to ease impact of FDA cuts - Yahoo Finance
ImmunityBio, Inc. (IBRX): Among Stocks Under $10 that Will Triple - Yahoo Finance
Cannara Biotech Inc.'s (CVE:LOVE) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum? - Yahoo Finance
Augustine Therapeutics appoints Industry Veteran Pascale Witz as Chair of its Board of Directors - Yahoo Finance
General Oncology Appoints Seasoned Biotech Executive Abid Ansari as Chief Financial Officer - Yahoo Finance
Oragenics, Inc. Participates in the 3rd Nasal Formulation & Delivery Summit - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Small Cap Stocks To Add to Your WatchlistMarch 29th - MarketBeat
Pre-market Movers: ICCT, CTOR, PCVX, AIM... - RTTNews
Portage Biotech’s After-Hours Surge On Preclinical Tumor Trial Data Sends Retail Optimism Sky-High - Asianet Newsable
Portage Biotech Insider Buyers See Boost After Market Cap Rose US$9.0m - simplywall.st
Promising Biotech Stocks To Watch Now – March 28th - Defense World
Portage Biotech (NASDAQ:PRTG) vs. Cytokinetics (NASDAQ:CYTK) Head-To-Head Survey - Defense World
Biotech Firms Celebrate Gains With Promising Trials And Partnerships - Finimize
Satellos Bioscience (TSE:MSCL) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Why Is Portage Biotech Stock Skyrocketing Friday? - Benzinga
Dow Tumbles Over 500 Points; Abacus Global Management Shares Spike Higher - Benzinga
Nasdaq Down 100 Points; Federal Reserve's Favorite Inflation Gauge Increases More Than Expected - Benzinga
Pre-market Movers: PRTG, RNAZ, PTIX, LGMK... - RTTNews
Portage Biotech (PRTG) Shares Skyrocket In Pre-Hour Trading - Stocks Telegraph
Why Braze Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket - Benzinga
PRTG Soars On Mesothelioma Data, NVNO Awaits FDA Decision, CureVac Jumps On Patent News - RTTNews
Portage Biotech Shares Jump Premarket After 'Promising' Preclinical Results in Mesothelioma - Marketscreener.com
Portage Biotech Reports Promising Preclinical Results in Mesothelioma Supporting First-In-Human Trial of PORT-7 - The Manila Times
Portage Biotech presents preclinical data for PORT-7 - TipRanks
Portage Biotech reports promising mesothelioma treatment data By Investing.com - Investing.com Australia
Portage Reports 'Promising' Preclinical Results in Mesothelioma - MarketScreener
Portage Biotech Announces Promising Preclinical Results for PORT-7 in Mesothelioma - TipRanks
Portage Biotech Reports Promising Preclinical Results In Mesothelioma Supporting First-In-Human Trial Of Port-7 - MarketScreener
Portage Biotech reports promising mesothelioma treatment data - Investing.com
Portage Biotech stock soars on promising preclinical data - Investing.com
Portage Biotech stock soars on promising preclinical data By Investing.com - Investing.com Canada
Game-Changing Mesothelioma Treatment: New Drug Achieves 90% Tumor Reduction in Latest Study - Stock Titan
LINKBANCORP, INC. Announces Receipt of Regulatory Approvals for New Jersey Branch Sale - Yahoo Finance
Is BioMarin Pharmaceutical Inc. (BMRN) a Promising Biotech Stock According to Wall Street Analysts - Yahoo Finance
Cannara Biotech Announces Appointment of Justin Cohen to Board of Directors - Yahoo Finance
Atea Pharmaceuticals, Inc. (AVIR): A Bull Case Theory - Yahoo Finance
Portage Biotech Inc Stock (PRTG) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.69%
21.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):